1. Home
  2. ALLR vs DUO Comparison

ALLR vs DUO Comparison

Compare ALLR & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • DUO
  • Stock Information
  • Founded
  • ALLR 2004
  • DUO 2011
  • Country
  • ALLR United States
  • DUO China
  • Employees
  • ALLR N/A
  • DUO N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • DUO Real Estate
  • Sector
  • ALLR Health Care
  • DUO Finance
  • Exchange
  • ALLR Nasdaq
  • DUO Nasdaq
  • Market Cap
  • ALLR 13.3M
  • DUO 11.4M
  • IPO Year
  • ALLR N/A
  • DUO 2019
  • Fundamental
  • Price
  • ALLR $1.00
  • DUO $2.18
  • Analyst Decision
  • ALLR
  • DUO
  • Analyst Count
  • ALLR 0
  • DUO 0
  • Target Price
  • ALLR N/A
  • DUO N/A
  • AVG Volume (30 Days)
  • ALLR 464.0K
  • DUO 178.9K
  • Earning Date
  • ALLR 08-04-2025
  • DUO 07-07-2025
  • Dividend Yield
  • ALLR N/A
  • DUO N/A
  • EPS Growth
  • ALLR N/A
  • DUO N/A
  • EPS
  • ALLR N/A
  • DUO 7.57
  • Revenue
  • ALLR N/A
  • DUO $46,458,330.00
  • Revenue This Year
  • ALLR N/A
  • DUO N/A
  • Revenue Next Year
  • ALLR N/A
  • DUO N/A
  • P/E Ratio
  • ALLR N/A
  • DUO $0.30
  • Revenue Growth
  • ALLR N/A
  • DUO 19.00
  • 52 Week Low
  • ALLR $0.61
  • DUO $2.13
  • 52 Week High
  • ALLR $7.45
  • DUO $74.72
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 54.51
  • DUO 29.52
  • Support Level
  • ALLR $0.80
  • DUO $2.33
  • Resistance Level
  • ALLR $1.09
  • DUO $2.49
  • Average True Range (ATR)
  • ALLR 0.07
  • DUO 0.23
  • MACD
  • ALLR 0.02
  • DUO -0.00
  • Stochastic Oscillator
  • ALLR 63.03
  • DUO 3.76

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About DUO Fangdd Network Group Ltd.

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Share on Social Networks: